Mohammed Farooqui

Statistics

Publications

Citations

2.9K

H-Index

Active since

2011

Affiliations

National Heart Lung and Blood Institute(Current)

National Institutes of Health

National Cancer Institute

National Institutes of Health Clinical Center

Center for Cancer Research

Mohammed Farooqui is an author at National Heart Lung and Blood Institute specializing in chronic lymphocytic leukemia therapy, medicine, and immunotherapy.

Publications per year

2011–2021

Publications

Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial

Mohammed Farooqui, Janet Valdez, Sabrina Martyr et al. · The Lancet Oncology · 2014 · 366 citations · Full text

Medicine, Immunology, Oncology +11

Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia

Inhye E. Ahn, Chingiz Underbayev, Adam Albitar et al. · Blood · 2017 · 342 citations · Full text

Medicine, Molecular Biology, Oncology +14

Ibrutinib inhibits BCR and NF-κB signaling and reduces tumor proliferation in tissue-resident cells of patients with CLL

Sarah E. M. Herman, Rashida Z. Mustafa, Jennifer Gyamfi et al. · Blood · 2014 · 242 citations

Medicine, Cancer Biology, Oncology +14

Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib

Clare Sun, Xin Tian, Yuh Shan Lee et al. · Blood · 2015 · 221 citations · Full text

Life Sciences, Hematology, Immunology +14

Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study

Inhye E. Ahn, Mohammed Farooqui, Xin Tian et al. · Blood · 2018 · 204 citations · Full text

Medicine, Pharmacology, Pharmacodynamics +4

1–5 of 28